Products

What will AGI do for Bepotastine?

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HYD2U48IAS. European Medicines Agency schedules Bepotastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05778MIG. Bepotastine generally arises in the molecular formula C21H25CLN2O3. The term BEPOTASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 2 1999, list 40.) Most nations schedule bepotastine under HS 29333999 and SITC 51574. As of Q4 2014, BEPOTASTINE remains the US FDA Preferred Term for this commodity. Bepotastine bears US NLM identifiers UMLS ID C2698371 and NCI Concept Code C77431. SMILES: C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.

How AGI delivers it

Four ways AGI delivers for Bepotastine

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Bepotastine, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Bepotastine, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Bepotastine connects

measured by

  • Active Ingredient Potencymodel
  • Assay Puritymodel
  • Chiral Enantiomeric Excessmodel
  • Chromatographic Assay Puritymodel
  • Compound Puritymodel
  • Optical Rotationmodel
  • Residual Solventmodel